`

Mesoblast Limited

Biotechnology Research

Specialities :
Cell-based therapies
Cellular medicines
Mesenchymal lineage adult stem cells
Regenerative medicine
Covid-19

+4

revenue-icon Revenue
1M - 10M
funding-icon Total Funding
$40.0M
size-icon Size
51 - 200

Frequently Asked Questions About Mesoblast Limited

What does Mesoblast limited do?+

Mesoblast (ASX:MSB; Nasdaq:MESO) is developing and commercializing allogeneic cellular medicines to treat serious and life-threatening inflammatory diseases with significant, unmet medical needs. The Companys Phase 3 off-the-shelf mesenchymal lineage cell product candidates are: RYONCILTM (remestemcel-L) for steroid-refractory acute graft versus host disease (acute GVHD) Remestemcel-L for moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19 infection REVASCOR for advanced chronic heart failure, and MPC-06-ID for chronic low back pain due to degenerative disc disease. The Companys proprietary manufacturing processes yield industrial-scale, cryopreserved, off-the-shelf, cellular medicines. These cell therapies, with defined pharmaceutical release criteria, are planned to be readily...

What are Mesoblast limited's specialties? +

Cell-based therapies,cellular medicines,mesenchymal lineage adult stem cells,regenerative medicine,covid-19,chronic heart failure,graft versus host disease,chronic low back pain,and rheumatoid arthritis

What is Mesoblast limited's industry? +

Mesoblast limited operates in the Biotechnology research industry.

What is Mesoblast limited's revenue? +

Mesoblast limited's revenue is 1m - 10m

What is Mesoblast limited's company size? +

Mesoblast limited has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.